Novartis AG vs Palantir Technologies Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Palantir Technologies Inc trades at $132.26 (market cap $323.28B). The key difference: Novartis AG and Palantir Technologies Inc are close in size by market cap, and Novartis AG pays a 3.17% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals.
| NVS | PLTR | |
|---|---|---|
Market Cap | $290.25B | $323.28B |
Sector | Health | Technology |
52-Week High | $168.62 | $207.18 |
52-Week Low | $113.50 | $107.27 |
Enterprise Value | $330.27B | $315.46B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →